Yennu Nanda VG, Gammon S, Prasad R, Knighton B, Pisaneschi F, Feng N, Williams L, Pramanik S, Sudderth J, Sui D, Fischer GM, Deng W, Peng W, Wang J, McQuade JL, Tetzlaff M, Di Francesco ME, Marszalek J, Piwnica-Worms D, DeBerardinis RJ, Davies MA
For some researchers, that premium buys peace of mind
Love what youre reading
You could imagine, some technology comes along that makes drug development way cheaper or makes us able to massively collapse the time and dollars spent in a clinical trial by using AI or something, or there might be ways to collapse costs 10x or 100x somewhere in the healthcare system
Human studies examining circulating METRNL levels have produced heterogeneous results, reflecting differences in metabolic state, physical activity, and assay methodology
Ethan Lazarus, MD, MFOMA Clinical Nutrition Center Greenwood Village, CO (303) 750-9454